Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other Accumulated Expenses (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Other Accumulated Expenses for 16 consecutive years, with $29.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses fell 16.13% year-over-year to $29.3 million, compared with a TTM value of $29.3 million through Sep 2025, down 16.13%, and an annual FY2024 reading of $34.4 million, down 1.23% over the prior year.
  • Other Accumulated Expenses was $29.3 million for Q3 2025 at Cross Country Healthcare, up from $590000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $35.9 million in Q4 2022 and bottomed at $590000.0 in Q2 2025.
  • Average Other Accumulated Expenses over 5 years is $17.6 million, with a median of $24.6 million recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses surged 2530.57% in 2022, then tumbled 98.34% in 2025.
  • Year by year, Other Accumulated Expenses stood at $1.4 million in 2021, then soared by 2530.57% to $35.9 million in 2022, then dropped by 2.87% to $34.9 million in 2023, then decreased by 1.23% to $34.4 million in 2024, then decreased by 14.99% to $29.3 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CCRN at $29.3 million in Q3 2025, $590000.0 in Q2 2025, and $34.0 million in Q1 2025.